Repositioning Candidate Details

Candidate ID: R0026
Source ID: DB00086
Source Type: approved; investigational
Compound Type: biotech
Compound Name: Streptokinase
Synonyms: Streptococcal fibrinolysin; Streptokinase
Molecular Formula: --
SMILES: --
DrugBank Description: Streptokinase, is a sterile, purified preparation of a bacterial protein elaborated by group C (beta) -hemolytic streptococci.
CAS Number: 9002-01-1
Molecular Weight:
DrugBank Indication: For the treatment of acute evolving transmural myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis or emolism and occlusion of arteriovenous cannulae
DrugBank Pharmacology: Streptokinase creates an active complex which promotes the cleavage of the Arg/Val bond in plasminogen to form the proteolytic enzyme plasmin. Plasmin in turn degrades the fibrin matrix of the thrombus, thereby exerting its thrombolytic action. This helps eliminate blood clots or arterial blockages that cause myocardial infarction.
DrugBank MoA: Plasminogen is an inactive molecule that becomes activated to plasmin when the Arg/Val bond is cleaved. Plasmin breaks down fibrin clots created by the blood clotting cascade. Streptokinase forms a highly specific 1:1 enzymatic complex with plasminogen which converts inactive plasminogen molecules into active plasmin. Plasmin degrades fibrin clots as well as fibrinogen and other plasma proteins. This in turn leads to the degradation of blood clots.
Targets: Plasminogen activator; Proteinase-activated receptor 1 activator
Inclusion Criteria: Indication associated